References
- Alves, G., Bronnick, K., Aarsland, D., Blennow, K., Zetterberg, H., Ballard, C., Kurz, M.W., Andreasson, U., Tysnes, O.B., Larsen, J.P., et al. (2010). CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. J. Neurol. Neurosurg. Psychiatry 81, 1080-1086. https://doi.org/10.1136/jnnp.2009.199950
- Ayton, S., Lei, P., Hare, D.J., Duce, J.A., George, J.L., Adlard, P.A., McLean, C., Rogers, J.T., Cherny, R.A., Finkelstein, D.I., et al. (2015). Parkinson's disease iron deposition caused by nitric oxide-induced loss of beta-amyloid precursor protein. J. Neurosci. 35, 3591-3597. https://doi.org/10.1523/JNEUROSCI.3439-14.2015
- Burgos, K., Malenica, I., Metpally, R., Courtright, A., Rakela, B., Beach, T., Shill, H., Adler, C., Sabbagh, M., Villa, S., et al. (2014). Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology. PLoS One 9, e94839. https://doi.org/10.1371/journal.pone.0094839
- Burte, F., Carelli, V., Chinnery, P.F., and Yu-Wai-Man, P. (2015). Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat. Rev. Neurol. 11, 11-24.
- Christopher, L., Duff-Canning, S., Koshimori, Y., Segura, B., Boileau, I., Chen, R., Lang, A.E., Houle, S., Rusjan, P., and Strafella, A.P. (2015). Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease. Ann. Neurol. 77, 269-280. https://doi.org/10.1002/ana.24323
- de Rijk, M.C., Breteler, M.M., Graveland, G.A., Ott, A., Grobbee, D.E., van der Meche, F.G., and Hofman, A. (1995). Prevalence of Parkinson's disease in the elderly: the Rotterdam study. Neurology 45, 2143-2146. https://doi.org/10.1212/WNL.45.12.2143
- Duce, J.A., Tsatsanis, A., Cater, M.A., James, S.A., Robb, E., Wikhe, K., Leong, S.L., Perez, K., Johanssen, T., Greenough, M.A., et al. (2010). Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer's disease. Cell 142, 857-867. https://doi.org/10.1016/j.cell.2010.08.014
- Exner, N., Lutz, A.K., Haass, C., and Winklhofer, K.F. (2012). Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences. EMBO J. 31, 3038-3062. https://doi.org/10.1038/emboj.2012.170
- Graves, P., and Zeng, Y. (2012). Biogenesis of mammalian microRNAs: a global view. Genomics Proteomics Bioinformatics 10, 239-245. https://doi.org/10.1016/j.gpb.2012.06.004
- Gray, N.E., Sampath, H., Zweig, J.A., Quinn, J.F., and Soumyanath, A. (2015). Centella asiatica attenuates amyloid-beta-induced oxidative stress and mitochondrial dysfunction. J. Alzheimers Dis. 45, 933-946. https://doi.org/10.3233/JAD-142217
- Guo, W., Jiang, L., Bhasin, S., Khan, S.M., and Swerdlow, R.H. (2009). DNA extraction procedures meaningfully influence qPCRbased mtDNA copy number determination. Mitochondrion 9, 261-265. https://doi.org/10.1016/j.mito.2009.03.003
- Irwin, D.J., Lee, V.M., and Trojanowski, J.Q. (2013). Parkinson's disease dementia: convergence of alpha-synuclein, tau and amyloid-beta pathologies. Nat. Rev. Neurosci. 14, 626-636. https://doi.org/10.1038/nrn3549
- Lees, A.J. (2007). Unresolved issues relating to the shaking palsy on the celebration of James Parkinson's 250th birthday. Mov. Disord. 22 Suppl 17, S327-334. https://doi.org/10.1002/mds.21684
- Liu, Y., Zhang, R.Y., Zhao, J., Dong, Z., Feng, D.Y., Wu, R., Shi, M., and Zhao, G. (2015). Ginsenoside Rd protects SH-SY5Y cells against 1-Methyl-4-phenylpyridinium induced Injury. Int. J. Mol. Sci. 16, 14395-14408. https://doi.org/10.3390/ijms160714395
- Luoma, P., Melberg, A., Rinne, J.O., Kaukonen, J.A., Nupponen, N.N., Chalmers, R.M., Oldfors, A., Rautakorpi, I., Peltonen, L., Majamaa, K., et al. (2004). Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study. Lancet 364, 875-882. https://doi.org/10.1016/S0140-6736(04)16983-3
- McCarthy, R.C., Park, Y.H., and Kosman, D.J. (2014). sAPP modulates iron efflux from brain microvascular endothelial cells by stabilizing the ferrous iron exporter ferroportin. EMBO Rep. 15, 809-815. https://doi.org/10.15252/embr.201338064
- Minones-Moyano, E., Porta, S., Escaramis, G., Rabionet, R., Iraola, S., Kagerbauer, B., Espinosa-Parrilla, Y., Ferrer, I., Estivill, X., and Marti, E. (2011). MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function. Hum. Mol. Genet. 20, 3067-3078. https://doi.org/10.1093/hmg/ddr210
- Nussbaum, R.L., and Ellis, C.E. (2003). Alzheimer's disease and Parkinson's disease. N. Engl. J. Med. 348, 1356-1364. https://doi.org/10.1056/NEJM2003ra020003
- Owen, A.D., Schapira, A.H.V., Jenner, P., and Marsden, C.D. (1996). Oxidative stress and Parkinson's diseasea. Anna. N Y Acad. Sci. 786, 217-223. https://doi.org/10.1111/j.1749-6632.1996.tb39064.x
- Pickrell, A.M., and Youle, R.J. (2015). The roles of PINK1, parkin, and mitochondrial fidelity in Parkinson's disease. Neuron 85, 257-273. https://doi.org/10.1016/j.neuron.2014.12.007
- Radad, K.S., Al-Shraim, M.M., Moustafa, M.F., and Rausch, W.D. (2015). Neuroprotective role of thymoquinone against 1-methyl-4-phenylpyridinium-induced dopaminergic cell death in primary mesencephalic cell culture. Neurosciences 20, 10-16.
- Reeve, A., Meagher, M., Lax, N., Simcox, E., Hepplewhite, P., Jaros, E., and Turnbull, D. (2013). The impact of pathogenic mitochondrial DNA mutations on substantia nigra neurons. J. Neurosci. 33, 10790-10801. https://doi.org/10.1523/JNEUROSCI.3525-12.2013
- Ruszkiewicz, J., and Albrecht, J. (2015). Changes in the mitochondrial antioxidant systems in neurodegenerative diseases and acute brain disorders. Neurochem. Int. 88, 66-72. https://doi.org/10.1016/j.neuint.2014.12.012
- Schapira, A.H.V. (1995). Oxidative stress in Parkinson's disease. Neuropathol. Appl. Neurobiol. 21, 3-9. https://doi.org/10.1111/j.1365-2990.1995.tb01022.x
- Schapira, A.H. (2009). Etiology and pathogenesis of Parkinson disease. Neurol. Clin. 27, 583-603, v. https://doi.org/10.1016/j.ncl.2009.04.004
- Schulte, E.C., Fukumori, A., Mollenhauer, B., Hor, H., Arzberger, T., Perneczky, R., Kurz, A., Diehl-Schmid, J., Hull, M., Lichtner, P., et al. (2015). Rare variants in beta-amyloid precursor protein (APP) and Parkinson's disease. Eur. J. Hum. Genet. 23, 1328-1333. https://doi.org/10.1038/ejhg.2014.300
- Sheng, B., Wang, X., Su, B., Lee, H.G., Casadesus, G., Perry, G., and Zhu, X. (2012). Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease. J. Neurochem. 120, 419-429. https://doi.org/10.1111/j.1471-4159.2011.07581.x
- Tan, L., and Yu, J.T. (2014). Causes and consequences of microRNA dysregulation in neurodegenerative diseases. Mol. Neurobiol. 51, 1249-1262.
- Tsou, Y.H., Shih, C.T., Ching, C.H., Huang, J.Y., Jen, C.J., Yu, L., Kuo, Y.M., Wu, F.S., and Chuang, J.I. (2015). Treadmill exercise activates Nrf2 antioxidant system to protect the nigrostriatal dopaminergic neurons from MPP+ toxicity. Exp. Neurol. 263, 50-62. https://doi.org/10.1016/j.expneurol.2014.09.021
- Vallelunga, A., Ragusa, M., Di Mauro, S., Iannitti, T., Pilleri, M., Biundo, R., Weis, L., Di Pietro, C., De Iuliis, A., Nicoletti, A., et al. (2014). Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and multiple system atrophy. Front Cell Neurosci. 8, 156.
- Westmark, C.J. (2013). What's hAPPening at synapses? The role of amyloid beta-protein precursor and beta-amyloid in neurological disorders. Mol. Psychiatry 18, 425-434. https://doi.org/10.1038/mp.2012.122
- Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R.C., et al. (1999). Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98, 115-124. https://doi.org/10.1016/S0092-8674(00)80611-X
- Zhang, X., Zuo, X., Yang, B., Li, Z., Xue, Y., Zhou, Y., Huang, J., Zhao, X., Zhou, J., Yan, Y., et al. (2014). MicroRNA directly enhances mitochondrial translation during muscle differentiation. Cell 158, 607-619. https://doi.org/10.1016/j.cell.2014.05.047
Cited by
- miRNAs Related to Skeletal Diseases vol.25, pp.17, 2016, https://doi.org/10.1089/scd.2016.0133
- The role of epigenetics in osteoarthritis vol.29, pp.1, 2017, https://doi.org/10.1097/BOR.0000000000000355
- MicroRNA-Mediated Rescue of Fear Extinction Memory by miR-144-3p in Extinction-Impaired Mice vol.81, pp.12, 2017, https://doi.org/10.1016/j.biopsych.2016.12.021
- MicroRNAs upregulated during HIV infection target peroxisome biogenesis factors: Implications for virus biology, disease mechanisms and neuropathology vol.13, pp.6, 2017, https://doi.org/10.1371/journal.ppat.1006360
- -galactose-induced brain aging via suppressing miR-34a-mediated autophagy impairment and abnormal mitochondrial dynamics vol.122, pp.6, 2017, https://doi.org/10.1152/japplphysiol.00018.2017
- Mitochondria in Neuroprotection by Phytochemicals: Bioactive Polyphenols Modulate Mitochondrial Apoptosis System, Function and Structure vol.20, pp.10, 2019, https://doi.org/10.3390/ijms20102451
- Relationship between single nucleotide polymorphisms in the 3′UTR of amyloid precursor protein and risk of Alzheimer’s disease and its mechanism vol.39, pp.5, 2016, https://doi.org/10.1042/bsr20182485
- Biological and Clinical Relevance of microRNAs in Mitochondrial Diseases/Dysfunctions vol.39, pp.8, 2016, https://doi.org/10.1089/dna.2019.5013
- MicroRNA-146a inhibition promotes total neurite outgrowth and suppresses cell apoptosis, inflammation, and STAT1/MYC pathway in PC12 and cortical neuron cellular Alzheimer's disease models vol.54, pp.5, 2016, https://doi.org/10.1590/1414-431x20209665
- A Review of miRNAs as Biomarkers and Effect of Dietary Modulation in Obesity Associated Cognitive Decline and Neurodegenerative Disorders vol.14, pp.None, 2021, https://doi.org/10.3389/fnmol.2021.756499